Edwards Lifesciences (EW) stock price, revenue, and financials

Edwards Lifesciences market cap is $71.4 b, and annual revenue was $4.39 b in FY 2020

$71.4 B

EW Mkt cap, 12-Nov-2021

$1.4 B

Edwards Lifesciences Revenue Q2, 2021
Edwards Lifesciences Gross profit (Q2, 2021)1 B
Edwards Lifesciences Gross profit margin (Q2, 2021), %75.7%
Edwards Lifesciences Net income (Q2, 2021)489.5 M
Edwards Lifesciences EBIT (Q2, 2021)542.1 M
Edwards Lifesciences Cash, 30-Jun-20211.3 B
Edwards Lifesciences EV70.7 B
Get notified regarding key financial metrics and revenue changes at Edwards LifesciencesLearn more
Banner background

Edwards Lifesciences Revenue

Edwards Lifesciences revenue was $4.39 b in FY, 2020 which is a 0.9% year over year increase from the previous period.

Embed Graph

Edwards Lifesciences Revenue Breakdown

Embed Graph

Edwards Lifesciences revenue breakdown by business segment: 16.5% from Critical Care, 17.4% from Surgical Structural Heart, 65.1% from Transcatheter Aortic Valve Replacement and 1.0% from Other

Edwards Lifesciences revenue breakdown by geographic segment: 9.9% from Rest of World, 10.5% from Japan, 22.2% from Europe and 57.4% from United States

Edwards Lifesciences Income Statement

Annual

USDFY, 2018FY, 2019FY, 2020

Revenue

3.7b4.3b4.4b

Revenue growth, %

8%17%1%

Cost of goods sold

939.4m1.1b1.1b

Gross profit

2.8b3.2b3.3b

Gross profit Margin, %

75%74%75%

R&D expense

622.2m752.7m760.7m

General and administrative expense

1.1b1.2b1.2b

Operating expense total

2.0b2.1b2.4b

EBIT

748.2m1.1b897.6m

EBIT margin, %

20%26%20%

Interest expense

29.9m20.7m15.8m

Interest income

32.0m32.2m23.4m

Pre tax profit

761.4m1.2b916.7m

Income tax expense

39.2m119.6m93.3m

Net Income

722.2m1.0b823.4m

EPS

3.44.91.3

Edwards Lifesciences Balance Sheet

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

818.3m714.1m1.2b1.2b

Accounts Receivable

421.6m456.9m543.6m514.6m

Prepaid Expenses

60.6m54.3m59.1m75.1m

Inventories

554.9m607.0m640.9m802.3m

Current Assets

2.5b2.3b3.0b3.1b

PP&E

679.7m867.5m1.1b1.4b

Goodwill

1.1b1.1b1.2b1.2b

Total Assets

5.7b5.3b6.5b7.2b

Accounts Payable

116.6m134.0m180.4m196.5m

Short-term debt

636.6m25.5m27.2m

Current Liabilities

1.4b876.6m902.4m893.9m

Long-term debt

438.4m593.8m653.3m667.7m

Total Debt

1.1b593.8m678.8m694.9m

Common Stock

212.0m215.2m218.1m636.4m

Additional Paid-in Capital

1.2b1.4b1.6b1.4b

Retained Earnings

2.0b2.7b3.7b4.6b

Total Equity

3.0b3.1b4.1b4.6b

Debt to Equity Ratio

0.4 x0.2 x0.2 x0.2 x

Debt to Assets Ratio

0.2 x0.1 x0.1 x0.1 x

Financial Leverage

1.9 x1.7 x1.6 x1.6 x

Edwards Lifesciences Cash Flow

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

583.6m722.2m1.0b823.4m

Depreciation and Amortization

81.9m77.4m89.3m107.2m

Accounts Receivable

(3.9m)(28.7m)(88.0m)41.9m

Inventories

(124.0m)(65.7m)(105.4m)(120.6m)

Accounts Payable

85.2m192.5m(63.5m)(84.5m)

Cash From Operating Activities

1.0b926.8m1.2b1.1b

Purchases of PP&E

(168.1m)(238.7m)(254.4m)(407.0m)

Cash From Investing Activities

(647.2m)76.7m(595.8m)(531.1m)

Long-term Borrowings

(818.4m)(1.1b)(28.9m)(17.0m)

Cash From Financing Activities

(473.2m)(1.1b)(115.6m)(486.9m)

Net Change in Cash

(111.8m)(104.2m)465.0m15.8m

Interest Paid

19.9m30.1m19.9m

Income Taxes Paid

143.7m223.7m61.5m

Edwards Lifesciences Ratios

USDFY, 2017

Debt/Equity

0.4 x

Debt/Assets

0.2 x

Financial Leverage

1.9 x

Edwards Lifesciences Operating Metrics

FY, 2017FY, 2018FY, 2019FY, 2020

Countries

100100100

Manufacturing Facilities

7777

Patents and Patent Applications

3.6 k3.9 k4.7 k

Edwards Lifesciences Employee Rating

4911 votes
Culture & Values
3.9
Work/Life Balance
3.6
Senior Management
3.5
Salary & Benefits
4.1
Career Opportunities
3.7
Source